[Cervical ripening at term. A randomized and prospective study: Misoprotol versus dinoprostone]

Area of Science:

• Obstetrics and Gynecology
• Reproductive Medicine
• Pharmacology

Context:

• Cervical ripening is crucial for labor induction in term pregnancies.
• Vaginal prostaglandins are commonly used for cervical ripening.
• Comparing Misoprostol and Dinoprostone efficacy and safety is essential for clinical practice.

Purpose:

• To compare the efficacy and safety of vaginal Misoprostol versus Dinoprostone for cervical ripening at term.
• To evaluate key labor induction parameters including time to labor, delivery duration, and birth rate within 24 hours.
• To assess the need for oxytocin augmentation and the mode of delivery in both treatment groups.

Summary:

• A prospective randomized study involving 300 patients compared vaginal Misoprostol and Dinoprostone for cervical ripening.
• Misoprostol significantly decreased time to labor (9.08 vs. 12.51 hours) and delivery duration (14.48 vs. 19.30 hours).
• Higher birth rates within 24 hours (86.7% vs. 72.7%) and reduced oxytocin use (44% vs. 58.7%) were observed with Misoprostol, with no significant difference in delivery mode.

Impact:

• Misoprostol demonstrates superior efficacy in accelerating labor induction and delivery compared to Dinoprostone.
• The findings suggest Misoprostol as a potentially more effective agent for cervical ripening, potentially reducing interventions like oxytocin.
• This research provides valuable data for obstetricians considering pharmacological methods for labor induction at term.